A randomized controlled trial of ivabradine in patients with acute myocardial infarction related cardiogenic shock.
Alejandro Alcaraz-GuzmánEder Jonathan Amaro-PalomoArturo Maximiliano Ruiz-BeltránBraiana Ángeles Díaz-HerreraRaúl Rodrigo Neri-BaleLilia Hernández-BravoManuel A Candia-RamírezRodrigo Gopar-NietoHector Gonzalez-PachecoJorge Daniel Sierra-Lara MartinezAlexandra Arias-MendozaDiego Araiza-GaraygordobilPublished in: Archivos peruanos de cardiologia y cirugia cardiovascular (2024)
. The use of ivabradine in patients with AMI-CS was associated with a significant reduction in heart rate at 12 and 48 h, without affecting other hemodynamic parameters.